Takeda Pharmaceutical Company Limited (4502) 📈: отчетность и дивиденды за 2025

Capitalização

Ifrs

Relatórios Anual Trimestral

	2018	2019	2020	2021	2022	2023	2024	LTM	Média de 5 anos	CAGR 5
Capitalização, bilhão ¥				4 807.62	6 700	6 595.01		6 830	6034.21	11.11
Receita, bilhão ¥	1 770.53	2 097.22	3 291.19	3 197.81	3 569.01	4 027.48	4 263.76	4 263.76	3669.85	5.31
Lucro líquido, bilhão ¥	186.89	109.13	44.24	376.01	230.06	317.02	144.07	144.07	222.28	26.63
EV, bilhão ¥		9 420.2	9 417.42	10 027.81	9 085.2	10 677.75	10 998.11	10 998.11	10041.26	3.15
EBIT, bilhão ¥		143.17	100.41	509.27	600.06	520.11	146.6	146.6	375.29	7.86
Ebitda, bilhão ¥	431.44	415.61	671.86	1 056.55	1 183.21	1 184.51	874.6	874.6	994.15	5.42
Oibda ¥			936.5	1 116.98	1 414	1 358	944.61	944.61	1154.02	0.17
Valor do equilíbrio, bilhão ¥	1 557.31	1 569.37	1 369.97	1 509.91	5 683.02	6 354.12	7 273.26	7 273.26	4438.06	39.64
FCF, bilhão ¥	249.59	194.37	452.04	774.46	937.07	343.47	235.61	235.61	548.53	-12.22
Opera.Mnoe Stream, bilhão ¥	377.85	328.48	669.75	1 010.93	1 123.11	977.16	716.34	716.34	899.46	1.35
Lucro operacional, bilhão ¥	241.79	160.37	274.71	338.31	460.84	490.51	214.08	214.08	355.69	-4.86
Ópera. Despesas, bilhões ¥	1 032.82	1 277.17	1 926.72	1 865.19	2 001.32	2 292.9	2 618.18	2 618.18	2140.86	6.33
Capex, bilhão ¥	128.26	134.11	217.71	236.47	186.04	633.69	480.73	480.73	350.93	17.17

	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	Média de 5 trimestres	CAGR 5
Receita, bilhão ¥	1 002.31	1 096.55	149 907.27	1 058.62	1 043.09	1 111.19	1 050.87	1 207.99	1 176.04	1 144.12	1138.04	0.59
Lucro líquido, bilhão ¥	61.74	119.13	4 881.23	89.4	-48.03	105.72	-3.02	95.25	92.05	23.79	62.76	-25.79
EV, bilhão ¥	9 786.87	10 043.61	1 690 094.42	11 515.67	11 625.69	10 801.87	10 948.55	11 183.9	10 798.14	11 167.95	10980.08	0.67
EBIT, bilhão ¥	104.44	186.9	14 243.26	194.61	-39.98	104.91	0.534	192.33	187.83	58	108.72	-11.18
Ebitda, bilhão ¥	286.19	363.78	39 549.31	366.11	200.26	291.98	187.28	384.55	380.28	244.96	297.81	-3.45
Oibda ¥						291.17	190.83	509.01	472.48	288.11	350.32	-0.21
Valor do equilíbrio, bilhão ¥	1 530.2	6 175.98	996 206.8	6 921.05	7 070.35	6 741.93	7 273.26	7 798.42	6 920.75	7 418.27	7230.53	1.93
FCF, bilhão ¥	180.38	327.61	-23 577.85	-176.84	128.86	69.33	208.15	21.58	209.53	327.11	167.14	36.38
Opera.Mnoe Stream, bilhão ¥	220.99	378.23	46 045.54	92.4	198.91	146.45	272.47	159.38	259	383.76	244.21	21.25
Lucro operacional, bilhão ¥	104.44	146.99	13 884.86	168.57	-49.34	104.91	0.534	219.71	184.25	66.94	115.27	-8.59
Ópera. Despesas, bilhões ¥	592.43	613.59	87 455.68	568.93	748.85	665.29	481.09	438.49	443.85	660.31	537.81	-0.15
Capex, bilhão ¥	40.61	50.62	69 623.39	269.24	70.04	77.12	64.33	137.8	49.47	56.65	77.07	-5.98

	Média de 5 trimestres	CAGR 5

Fluxo de caixa O fluxo de caixa é trimestralmente Ativos

Saldo contábil

Ifrs

Relatórios Anual Trimestral

	2018	2019	2020	2021	2022	2023	2024	LTM	Média de 5 anos	CAGR 5
Dinheiro, bilhão ¥	294.52	702.09	637.61	966.22	849.7	533.53	457.8	457.8	688.97	-6.41
Investimentos de curto prazo ¥		23.28	15.82	36.6	25.31	20.17	15.09	15.09	22.60	-0.94
Contas a receber ¥		749.12	784.92	812.71	724.38	681.69	697.61	697.61	740.26	-2.33
Total de ativos circulantes ¥		3 050.66	2 469.43	2 712.89	2 593.64	2 397.96	2 558.58	2 558.58	2546.50	0.71
Ativos puros, bilhões ¥	1 997.42	5 159.58	4 723.48	5 173.04	1 582.8	1 691.23		1 691.23	3666.03	-19.99
Ativos, bilhões ¥	4 106.46	13 872.32	12 821.09	12 912.29	13 178.02	13 957.75	15 108.79	15 108.79	13595.59	3.34
Dívida de curto prazo ¥		984.95	586.82	22.15	257.87	399.22	367.25	367.25	326.66	-8.95
Dívida de longo prazo ¥		4 766.01	4 506.49	4 613.22	4 141.42	4 042.74	4 476.5	4 476.5	4356.07	-0.13
Dívida, bilhão ¥	2 089.05	8 708.73	8 093.61	7 735.12	7 494.5	7 603.08	7 834.79	7 834.79	7752.22	-0.65
Dívida pura, bilhão ¥	691.14	5 048.86	4 455.69	3 669.15	3 495.72	3 848.81	4 385.95	4 385.95	3971.06	-0.32
Dívida, bilhão ¥	985.66	5 750.95	5 093.3	4 635.37	4 345.41	4 382.34	4 843.75	4 843.75	4660.03	-1.00
Despesas com juros, bilhões ¥		48.16	149.01	130.81	166.61	169.7	153.63	153.63	153.95	0.61
Renda de juros pura, bilhão ¥	39.54	6.62	11.2	105.52	23.7	62.91	11.29	62.91	42.92	0.16
Depreciação, bilhão ¥		272.45	587.49	665.27	583.15	664.4	728	728	645.66	4.38
Custo, bilhão ¥			1 089.76	994.31	1 106.85	1 244.07	1 431.51	1 431.51	1173.30	5.61
Suprimentos médicos ¥		986.74	759.6	753.88	853.17	986.46	1 209.87	1 209.87	912.60	9.76

	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	Média de 5 trimestres	CAGR 5
Dinheiro, bilhão ¥					798.14	685.14	83 647.47	316.38	318.05	288.36	457.8	804.27	859.02	494.13	580.72	11.37
Investimentos de curto prazo ¥					31.93	41.47	3 162.9	52.23	15.76	29.05	15.09	53.39	47.2	32.62	35.47	2.35
Contas a receber ¥					800.54	779.87	106 876.64	825.48	788.07	743.08	697.61	772.37	721.06	735.06	733.84	-0.22
Total de ativos circulantes ¥					2 745.62	2 595.95	375 954.39	2 472.02	2 462.07	2 428.83	2 558.58	3 107.53	3 054.01	2 754.29	2780.65	2.55
Ativos puros, bilhões ¥	5 323.94	5 331.33	5 683.02	6 316.83	6 712.93	1 656.42	265 152.89	1 795.32	1 894.14						55442.34	-22.36
Ativos, bilhões ¥					14 588.85	13 504.71	2 188 312.64	14 792.74	14 871.89	14 222.95	15 108.79	16 227.68	14 573	15 106.84	15047.85	1.21
Dívida de curto prazo ¥					568.23	372.02	53 242.89	416.86	274.84	370.29	367.25	438.74	624.1	135.47	387.17	-18.22
Dívida de longo prazo ¥					4 168.42	3 914.88	633 825.74	4 330.25	4 404.36	4 293.87	4 476.5	5 042.24	4 427.09	4 704.68	4588.88	1.84
Dívida, bilhão ¥					7 875.36	7 328.21	1 192 019.76	7 871.07	7 800.86	7 480.34	7 834.79	8 428.45	7 651.4	7 687.65	7816.53	0.55
Dívida pura, bilhão ¥					3 938.51	3 601.76	603 421.16	4 430.73	4 361.15	4 375.81	4 385.95	4 676.71	4 192.18	4 346.02	4395.33	-0.14
Dívida, bilhão ¥					4 736.65	4 286.9	687 068.63	4 747.11	4 679.2	4 664.16	4 843.75	5 480.99	5 051.19	4 840.15	4976.05	0.74
Despesas com juros, bilhões ¥					53.8	79.75	6 731.09	59.58	46.52	66.57	47.19	59.69	68.45	31.6	54.70	-13.84
Renda de juros pura, bilhão ¥		3.96	19.25	60.93	14.78	41.68	1 220.23	4 147.65	335.98	3 478.83	34.81				1843.50	-50.90
Depreciação, bilhão ¥					167.83	176.88	25 306.05	171.5	240.24	187.06	186.74	192.22	192.45	186.96	189.09	-0.01
Custo, bilhão ¥								321.11	343.58	379.48	569.25	549.79	536.73	416.87	490.42	1.90
Suprimentos médicos ¥					953.45	927.29	154 657.9	1 083.37	1 155.87	1 169.64	1 209.87	1 276.74	1 206.43	1 246.43	1221.82	1.28

	Média de 5 trimestres	CAGR 5

Promoção

Ifrs

Relatórios Anual Trimestral

	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Média de 5 anos	CAGR 5
EPS		237.56	112.86	28.25	238.96	145.87	201.94	91.16		91.16	141.24	26.40
O preço da ação do AO	6176	4627	4000	3899	3070	4033	4054	4181	4375	4375	3942.60	7.34
O número de ações da AO, milhões			966.9	1566.2	1566	1577.17	1569.87	1580.34		1580.34	1571.92	0.18
FCF/Promoção		317.27	201.02	288.62	492.18	594.15	218.79	149.09		149.09	348.57	-12.38

	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	Média de 5 trimestres	CAGR 5
EPS	39.28	75.86	3024.73	57.12	-30.68	66.7	-1.92	59.94	57.17	14.58			39.29	-26.22
O preço da ação do AO											4545	4375	4460.00	-1.89
FCF/Promoção	114.76	208.61	-93.19	-112.99	82.32	43.74	132.71	13.58	130.14	200.48			104.13	35.59

	Média de 5 trimestres	CAGR 5

Eficiência

Ifrs

Relatórios Anual Trimestral

	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Média na indústria	Média de 5 anos	CAGR 5
ROE, %	9.6	3.05	0.8953	7.6	4.24	5.27	2.11		2.11	7.97	4.02	18.70
Roa, %	4.42	1.21	0.3315	2.92	1.76	2.34	0.9913		0.9913	5.18	1.67	24.49
ROIC, %			3.34	6.73	5.08	5.63			5.63	10.25	5.20	13.94
Ros, %			1.34	11.76	6.45	7.87	3.38	3.38	3.38	5.81	6.57	-22.07
Roce, %		1.26	0.9432	4.57	5.44	4.53	1.15	2.02	2.02	10.34	3.54	-15.06
EBIT margem			9.01	13.26	16.81	12.91	3.44	3.44	3.44	9.29	9.97	-23.65
Lucratividade do EBITDA	24.37	19.82	20.41	33.04	33.15	29.41	20.51	20.51	20.51	14.67	27.32	-9.10
Pura lucratividade	10.56	5.2	1.34	11.76	6.45	7.87	3.38		3.38	6.99	6.16	20.33
Eficiência operacional, %			3.05	15.93	12.91	12.18	5.02	5.02	5.02	8.27	10.21	-20.62

	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	2025Q3	Média na indústria	Média de 5 trimestres	CAGR 5
ROE, %	1.06	1.95	0.4937	1.29	-0.7293	1.58	-0.0438	1.34	1.28	0.3273			7.97	0.8967	-27.01
Roa, %	0.4309	0.8481	0.2267	0.6043	-0.3238	0.7267	-0.0206	0.6079	0.5977	0.1603			5.18	0.4144	-26.09
ROIC, %				1.89	-0.3316	2.14	0.0504	1.76	0.8457	1.38			10.25	1.24	-8.40
Ros, %				8.44	-4.6	9.51	-0.2872	7.88	7.83	2.08	3.38	3.38	5.81	4.91	-15.57
Roce, %			0.7758	2.81	-0.3364	0.8704	0.0043	1.51	1.48	0.4483	2.02	2.02	10.34	1.50	5.99
EBIT margem					-3.83	9.44	0.0508	15.92	15.97	5.07	3.44	3.44	9.29	8.77	-26.39
Lucratividade do EBITDA			26.38	34.58	19.2	26.28	17.82	31.83	32.34	21.41	20.51	20.51	14.67	25.32	-8.41
Pura lucratividade	6.16	10.86	3.26	8.44	-4.6	9.51	-0.2872	7.88	7.83	2.08			6.99	5.40	-26.21
Eficiência operacional, %				15.92	-4.73	9.44	0.0508	18.19	15.67	5.85	5.02	5.02	8.27	9.95	-22.70

	Média na indústria	Média de 5 trimestres	CAGR 5

Coeficientes

Ifrs

Relatórios Anual Trimestral

	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Média na indústria	Média de 5 anos	CAGR 5
P/e	21.82	40.06	112.15	16.91	24.3	21.54	45.9		45.9	172.99	44.16	-16.36
P/bv		0.8466	1.05	1.23	0.9835	1.07	0.909		0.909	128.91	1.05	-2.84
P/s	2.3	2.08	1.51	1.99	1.57	1.7	1.55		1.55	129.26	1.66	0.52
P/fcf						19.89	28.99	28.99	28.99	31.32	25.96	13.38
E/p						0.0464	0.0211	0.0211	0.0211	0.16	0.0295	-23.10
EV/EBIT			31.74	23.65	15.14	20.53	75.02	75.02	75.02	145.62	41.87	25.97
EV/EBITDA	11.05	22.67	14.02	9.49	7.68	9.01	12.57		12.57	27.96	10.55	-2.16
EV/S			2.86	3.14	2.55	2.65	2.58	2.58	2.58	129.00	2.70	-3.85
EV/FCF			20.83	12.95	9.7	31.09	46.68	46.68	46.68	-104.04	29.42	29.23
Dívida/Ebitda	2.28	13.84	7.58	4.39	3.67	3.7	5.54	5.54	5.54	6.10	4.57	4.76
NetDebt/Ebitda			6.48	3.12	2.95	3.25	5.01	5.01	5.01	32.72	3.87	9.94
Dívida/índice			0.3973	0.359	0.3297	0.314	0.3206	0.3206	0.3206	0.14	0.3288	-2.24
Dívida/patrimônio líquido			1.08	0.8961	0.7646	0.6897	0.666	1.08	1.08	0.88	0.8193	3.80
Dívida/lucro líquido			115.13	12.33	18.89	13.82	33.62	33.62	33.62	3.70	22.46	22.22
Peg								-0.6443	-0.6443	-163.53	-0.6443	0.00
Beta					0.7	-0.9444	-0.3144	-0.0661	-0.0661	-0.05	-0.1562	-155.43
ÍNDICE ALTMAN					0	1.26	1.15	1.26	1.26	-14.05	1.22	0.00

	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	Média na indústria	Média de 5 trimestres	CAGR 5
P/e	11.23	30.11	27.58	23.35	21.24	23.61		36.06		43.55	22.56	32.22				172.99	31.60	6.42
P/bv			0.8711	1.04	1.09	1.02	1.03	0.9531	0.9022	0.8343	0.9544	0.9195				128.91	0.9127	-0.72
P/s			1.57	1.63	1.68	1.74	1.76	1.54	1.54	1.46	1.43	1.46				129.26	1.49	-1.06
P/fcf														28.99	28.99	31.32	28.99	0.00
E/p														0.0211	0.0211	0.16	0.0211	0.00
EV/EBIT							-290.77	102.96	20502.9	58.15	57.49	192.54		75.02	75.02	145.62	91.64	5.23
EV/EBITDA			9.49	8.81	8.48	31.45	10.29	9.84	10.66	10.51	8.68	9.33				27.96	9.80	-1.06
EV/S						10.88	11.15	9.72	10.42	9.26	9.18	9.76		2.58	2.58	129.00	6.67	-22.55
EV/FCF						-65.12	90.22	155.81	52.6	518.32	51.54	34.14		46.68	46.68	-104.04	139.47	-38.21
Dívida/Ebitda					17.37	12.97	23.37	15.97	25.86	14.25	13.28	19.76		5.54	5.54	6.10	11.67	-17.22
NetDebt/Ebitda						12.1	21.78	14.99	23.42	12.16	11.02	17.74		5.01	5.01	32.72	10.19	-16.25
Dívida/índice						0.3209	0.3146	0.3279	0.3206	0.3378	0.3466	0.3204		0.3206	0.3206	0.14	0.3292	-1.04
Dívida/patrimônio líquido						0.6859	0.6618	0.6918	0.666	0.7028	0.7299	0.6525		1.08	1.08	0.88	0.8490	8.97
Dívida/lucro líquido						53.1	-97.42	44.12	-1604.95	57.54	54.88	203.46		33.62	33.62	3.70	76.62	-10.19
Peg														-0.6443	-0.6443	-163.53	-0.6443	0.00
Beta													-1.92	0.0123	-0.0661	-0.05	-0.6579	-67.47
ÍNDICE ALTMAN													1.26	1.26	1.26	-14.05	1.26	0.00

Dividendos

Ifrs

Relatórios Anual Trimestral

	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Média na indústria	Média de 5 anos	CAGR 5
Div. Pagamento, bilhão	141.89	142.95	282.58	283.36	283.67	279.42	287.19			287.19		283.24	0.32
Dividendo	180	180	180	180	180	180	184	192	98	196		166.80	-11.45
Div renda, AO, %	2.91	4.23	4.04	4.62	5.86	7.17	5.9	6.89	6.43	6.66	3.03	6.45	1.87
Dividendos / lucro, %		75.92	131	638.73	75.36	123.3	88.14	199.34		199.34	44.95	224.97	-20.78
O coeficiente de revestimento de dividendos									0.5016	0.5016	1.45	0.5016	0.00

	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	2025Q3	Média na indústria	Média de 5 trimestres	CAGR 5
Div. Pagamento, bilhão	11.13	128.99	1633.5	130.75	9.07	138.25	9.13	138.11	9.2	145.45				88.03	1.02
Dividendos / lucro, %	18.03	108.28	33.47	146.26	-18.87	130.77	-302.39	145	9.99	611.42			44.95	118.96	36.13
O coeficiente de revestimento de dividendos											0.5016	0.5016	1.45	0.5016	0.00

	Média na indústria	Média de 5 trimestres	CAGR 5

Descansar

Ifrs

Relatórios Anual Trimestral

	2020	2021	2022	2023	2024	LTM	CAGR 5
Capex/Receita, %	6.61	7.39	5.21	15.73	11.27	11.27	11.26
No total, dívida	2 175.9	1 773.18					-9.73
Funcionários, pessoas			47 347	47 347	49 095		1.22

	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	CAGR 5
Capex/Receita, %	6.94	6.12	11.41	4.21	4.95	-6.53

	CAGR 5

Investing Port

Takeda Pharmaceutical Company Limited

Relatórios Takeda Pharmaceutical Company Limited

Capitalização

Saldo contábil

Promoção

Eficiência

Coeficientes

Dividendos

Pague a assinatura

Descansar